
Mark Lance Shibuya
Supervisory Patent Examiner (ID: 18151, Phone: (571)272-0806 , Office: P/1677 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 1641, 1677, 1624, 1635, 1678, 1639, 1631, 1674 |
| Total Applications | 606 |
| Issued Applications | 223 |
| Pending Applications | 123 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7183357
[patent_doc_number] => 20040203085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Method for parallel synthesis and transfer of molecules to a substrates'
[patent_app_type] => new
[patent_app_number] => 10/475801
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7231
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475801 | Method for parallel synthesis and transfer of molecules to a substrates | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7183130
[patent_doc_number] => 20040203046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Methods for modulating cellular and organismal phenotypes'
[patent_app_type] => new
[patent_app_number] => 10/832780
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24724
[patent_no_of_claims] => 185
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832780 | Methods for modulating cellular and organismal phenotypes | Apr 26, 2004 | Abandoned |
Array
(
[id] => 915256
[patent_doc_number] => 07326954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters'
[patent_app_type] => utility
[patent_app_number] => 10/816603
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11214
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816603 | Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters | Apr 1, 2004 | Issued |
Array
(
[id] => 6971718
[patent_doc_number] => 20050037428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods'
[patent_app_type] => utility
[patent_app_number] => 10/812850
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 39306
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10812850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/812850 | Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods | Mar 28, 2004 | Abandoned |
Array
(
[id] => 477969
[patent_doc_number] => 07223547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Polypeptides having a functional domain of interest and methods of identifying and using same'
[patent_app_type] => utility
[patent_app_number] => 10/807856
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 89
[patent_no_of_words] => 28517
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807856 | Polypeptides having a functional domain of interest and methods of identifying and using same | Mar 22, 2004 | Issued |
Array
(
[id] => 836360
[patent_doc_number] => 07393318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Methods and compositions for interaction trap assays'
[patent_app_type] => utility
[patent_app_number] => 10/801994
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52207
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801994 | Methods and compositions for interaction trap assays | Mar 15, 2004 | Issued |
Array
(
[id] => 7295882
[patent_doc_number] => 20040214183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Methods for global profiling gene regulatory element activity'
[patent_app_type] => new
[patent_app_number] => 10/468965
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12153
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468965 | Methods for global profiling gene regulatory element activity | Mar 14, 2004 | Abandoned |
Array
(
[id] => 377090
[patent_doc_number] => 07312190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders'
[patent_app_type] => utility
[patent_app_number] => 10/802080
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 41529
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312190.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802080 | Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Mar 14, 2004 | Issued |
Array
(
[id] => 7374714
[patent_doc_number] => 20040219580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Genome signature tags'
[patent_app_type] => new
[patent_app_number] => 10/791074
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22491
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791074 | Genome signature tags | Mar 1, 2004 | Issued |
Array
(
[id] => 7184959
[patent_doc_number] => 20050191704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Assay devices utilizing chemichromic dyes'
[patent_app_type] => utility
[patent_app_number] => 10/790617
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9332
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790617 | Assay devices utilizing chemichromic dyes | Feb 29, 2004 | Abandoned |
Array
(
[id] => 7432884
[patent_doc_number] => 20040209860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity'
[patent_app_type] => new
[patent_app_number] => 10/778649
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64171
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778649 | Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7154050
[patent_doc_number] => 20050026172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'siRNA libraries optimized for predetermined protein families'
[patent_app_type] => utility
[patent_app_number] => 10/776399
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13240
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776399 | siRNA libraries optimized for predetermined protein families | Feb 9, 2004 | Abandoned |
Array
(
[id] => 7286862
[patent_doc_number] => 20040146922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Cellular arrays for the identification of altered gene expression'
[patent_app_type] => new
[patent_app_number] => 10/772167
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 43771
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772167 | Cellular arrays for the identification of altered gene expression | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7308675
[patent_doc_number] => 20040142373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Cellular arrays for the identification of altered gene expression'
[patent_app_type] => new
[patent_app_number] => 10/772168
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 43774
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772168 | Cellular arrays for the identification of altered gene expression | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7195721
[patent_doc_number] => 20050164211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Carbon nanotube molecular labels'
[patent_app_type] => utility
[patent_app_number] => 10/763674
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9245
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164211.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763674 | Carbon nanotube molecular labels | Jan 21, 2004 | Abandoned |
Array
(
[id] => 7677692
[patent_doc_number] => 20040152134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Bicyclic melanocortin-specific compounds'
[patent_app_type] => new
[patent_app_number] => 10/761889
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20227
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761889 | Bicyclic melanocortin-specific compounds | Jan 20, 2004 | Issued |
Array
(
[id] => 7447200
[patent_doc_number] => 20040186079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Methods for diagnosis and treatment of PH domain signal transduction disorders'
[patent_app_type] => new
[patent_app_number] => 10/738259
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22378
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10738259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/738259 | Methods for diagnosis and treatment of PH domain signal transduction disorders | Dec 17, 2003 | Issued |
Array
(
[id] => 7332990
[patent_doc_number] => 20040131544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'In vivo imaging'
[patent_app_type] => new
[patent_app_number] => 10/739828
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11869
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10739828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/739828 | In vivo imaging | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7275600
[patent_doc_number] => 20040235051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Artificial receptors including amino acid derived building blocks and methods of making and using them'
[patent_app_type] => new
[patent_app_number] => 10/727059
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29615
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727059 | Artificial receptors including amino acid derived building blocks and methods of making and using them | Dec 1, 2003 | Abandoned |
Array
(
[id] => 7412244
[patent_doc_number] => 20040106680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Use of creatine or creatine analogs for the treatment of diseases of the nervous system'
[patent_app_type] => new
[patent_app_number] => 10/718846
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11547
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718846
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718846 | Use of creatine or creatine analogs for the treatment of diseases of the nervous system | Nov 20, 2003 | Issued |